Tumor-specific CD4+T cells develop cytotoxic activity and eliminate virus-induced tumour cells in the absence of regulatory T cells

被引：0
|
作者：
Akhmetzyanova, I. [1 ]
Zelinskyy, G. [1 ]
Schimmer, S. [1 ]
Sparwasser, T. [2 ]
Dittmer, U. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
[2] TWINCORE, Hannover, Germany
来源：
IMMUNOLOGY | 2012年 / 137卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：621 / 622
页数：2
相关论文
共 50 条
  • [1] Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
    Ilseyar Akhmetzyanova
    Gennadiy Zelinskyy
    Simone Schimmer
    Sven Brandau
    Petra Altenhoff
    Tim Sparwasser
    Ulf Dittmer
    Cancer Immunology, Immunotherapy, 2013, 62 : 257 - 271
  • [2] Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
    Akhmetzyanova, Ilseyar
    Zelinskyy, Gennadiy
    Schimmer, Simone
    Brandau, Sven
    Altenhoff, Petra
    Sparwasser, Tim
    Dittmer, Ulf
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (02) : 257 - 271
  • [3] CD4+ T Cells Develop Antiretroviral Cytotoxic Activity in the Absence of Regulatory T Cells and CD8+ T Cells
    Manzke, Nora
    Akhmetzyanova, Ilseyar
    Hasenkrug, Kim J.
    Trilling, Mirko
    Zelinskyy, Gennadiy
    Dittmer, Ulf
    JOURNAL OF VIROLOGY, 2013, 87 (11) : 6306 - 6313
  • [4] In vivo requirements for activation of tumor-specific CD4+T cells
    Corthay, A
    Bogen, B
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 156 - 156
  • [5] Regulation and impact of tumor-specific CD4+T cells in cancer and immunotherapy
    Guo, Mengdi
    Liu, Melissa Yi Ran
    Brooks, David G.
    TRENDS IN IMMUNOLOGY, 2024, 45 (04) : 303 - 313
  • [6] Differential Suppression of Tumor-Specific CD8+ T Cells by Regulatory T Cells
    James, Edward
    Yeh, Alex
    King, Cathy
    Korangy, Firouzeh
    Bailey, Ian
    Boulanger, Denise S.
    Van den Eynde, Benoit J.
    Murray, Nicholas
    Elliott, Tim J.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 5048 - 5055
  • [7] Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
    Church, Sarah E.
    Jensen, Shawn M.
    Antony, Paul A.
    Restifo, Nicholas P.
    Fox, Bernard A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 69 - 79
  • [8] Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4- T Cells
    Liu, Qiao
    Wang, Lisha
    Lin, Huayu
    Wang, Zhiming
    Wu, Jialin
    Guo, Junyi
    Wen, Shuqiong
    Ran, Ling
    Yue, Zhengliang
    Su, Xingxing
    Wu, Qing
    Tang, Jianfang
    Li, Zhirong
    Hu, Li
    Xu, Lifan
    Ye, Lilin
    Huang, Qizhao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [9] Varicella-zoster-virus-specific CD4+ cytotoxic T cells as tumor-specific effector cells in cancer immunotherapy.
    Landmeier, S
    Pscherer, S
    Eing, B
    Rooney, CM
    Juergens, H
    Rossig, C
    BLOOD, 2005, 106 (11) : 376A - 376A
  • [10] Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
    Antony , Paul
    Xie, Ying
    Akpinarli, Akgul
    Maris, Charles
    Hipkiss, Edward
    Lane, Malcolm
    Kwon, Eun-Kyung
    Muranski, Pawel
    Restifo, Nicholas
    JOURNAL OF IMMUNOLOGY, 2010, 184
12345